IM Cannabis Corp.
IMCCHealthcareNASDAQDrug Manufacturers - Specialty & Generic · Last scanned Oct 24, 2026
Scan Results
Daily timeframeIM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. The company carries a $1.4M market cap, placing it firmly in the micro-cap category. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands.
Market Cap
$1.4M
Beta
2.21
P/E (TTM)
—
P/E (Fwd)
-0.68
EPS (TTM)
$-68.30
EPS (Fwd)
$-1.30
ROE
—
ROA
-18.6%
Cash
$1.6M
Total Debt
$13.8M
Free CF
-$2.1M
52W Change
-98.0%
Annual Financials
Cash vs Debt
Where IMCC stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, IMCC finished 75.85% below its 150-day moving average ($6.21) and 88.51% below its 200-day moving average ($13.05). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is IMCC overbought or oversold?
At the October 20, 2026 close, IMCC's RSI(14) was 13.2, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
IM Cannabis Corp. carries $13.8M in total debt against $1.6M in cash reserves — debt is roughly 8.6x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow is running at -$2.1M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Revenue has been relatively flat, moving from $54.3M (2022) to $54.7M (2025).
With a beta above 1.5, IMCC tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing IMCC.